Metabolic Reprogramming Helps to Define Different Metastatic Tropisms in Colorectal Cancer

Metabolic Reprogramming Helps to Define Different Metastatic Tropisms in Colorectal Cancer

Approximately 25% of colorectal cancer (CRC) patients experience systemic metastases, with the most frequent target organs being the liver and lung. Metabolic reprogramming has been recognized as one of the hallmarks of cancer. Here, metabolic and functional differences between two CRC cells with di...

Full description

Bibliographic Details
Main Authors: Ana Montero-Calle, Marta Gómez de Cedrón, Adriana Quijada-Freire, Guillermo Solís-Fernández, Victoria López-Alonso, Isabel Espinosa-Salinas, Alberto Peláez-García, María Jesús Fernández-Aceñero, Ana Ramírez de Molina, Rodrigo Barderas
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Oncology
Subjects:
CRC (colorectal cancer)
metabolic reprograming
tropism of metastasis
obesity
fatty acids (FA)
organotropism
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.903033/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.903033/full

Similar Items